Intervention

Efsubaglutide Alfa Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions5

Lead sponsors shown2

Clinical trials

3 shown

Evaluating Anti-Obesity Medications 6 Months After Metabolic SurgeryNCT07163650 · 2025-09-16

A Bridging Study of Efsubaglutide Alfa in Healthy Adults in BrazilNCT07518121 · 2026-06-01

NOT_YET_RECRUITING

A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.NCT06849843 · 2024-12-18

Common conditions

Diabete Type 21 Metabolic Surgery1 Obesity1 Type2 Diabetes1 Weight Loss1

Leading sponsors

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1

Trial status mix

COMPLETED1

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.